Timing of indicated delivery after antenatal steroids in preterm pregnancies with severe hypertension

Hypertension in Pregnancy

Volumn 28, Issue 1, 2009, Pages 63-75

  Ferguson, Shaun ^a   Allen, Victoria M ^a,b   Craig, Catherine ^a   Allen, Alexander C ^a   Dodds, Linda ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b IWK HEALTH CENTRE   (Canada)

Author keywords

Antenatal steroids; Hypertension; Preterm

Indexed keywords

BETAMETHASONE; DEXAMETHASONE;

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GESTATION PERIOD; HUMAN; INFANT; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL PERIOD; PROPHYLAXIS; RISK ASSESSMENT;

ADULT; BETAMETHASONE; DELIVERY, OBSTETRIC; FEMALE; FETAL ORGAN MATURITY; GLUCOCORTICOIDS; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LOGISTIC MODELS; LUNG; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 60749087062     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950802366237     Document Type: Article

References (32)

1. Rochat RW, Koonin LM, Atrash HK, Jewett JF, the Maternal Mortality Collaborative. Maternal mortality in the United States: Report from the Maternal Mortality Collaborative. Obstet Gynecol 1988;72:91-97.
2. de Swiet M. Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom. Am J Obstet Gynecol 2000;182:760-766.
3. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001;322:1089-1093.
4. ACOG Committee Opinion: Antenatal corticosteroid therapy for fetal lung maturation. Obstet Gynecol 2002;99:871-873.
5. Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171:1148-1153.
6. Isler CM, Barrilleux, Magann EF, Bass JD, Martin JN. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2001;184:1332-1339.
7. O'Brien JM, Shumate SA, Satchwell SL, Milligan DA, Barton JR. Maternal benefit of corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: impact on the rate of regional anesthesia. Am J Obstet Gynecol 2002;186:475-479.
8. O'Brien JM, Milligan DA, Barton JR. Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 2000;183:921-924.
9. Tompkins MJ, Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids. Am J Obstet Gynecol 1999;181:304-309.
10. Matchaba P, Moodley J. Corticosteroids for HELLP syndrome in pregnancy Cochrane Database of Systematic Reviews 2004, Issue 1. Art No.: CD002076. pub2. DOI: 10.1002/14651858.CD002076.pub2.
11. Crane JMG, Tabarsi B, Hutchens D. The maternal benefirts of corticosteroids with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. J Obste Gynecol Can 2003;25:650-655.
12. Martin JN, Thigpen BD, Rose CH, Cushman J, Moore A, May WA. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet Gynecol 2003;189:830-834.
13. Piazze JJ, Maranghi L, Nigro G, Rizzo G, Cosmi EV, Anceschi MM. The effect of glucocorticoid therapy on fetal lung maturity indices in hypertensive pregnancies. Obstet Gynecol 1998;92:220-225.
14. Schlembach D, Munz W, Fischer T. Effect of steroids on HELLP syndrome: a case report. J Perinat Med 2000;28:502-505.
15. Magann EF, Martin JN. Critical care of HELLP syndrome with corticosteroids. Am J Perinatol 2000;17: 417-421.
16. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks gestation: A randomized controlled trial. Am J Obstet Gynecol 1994;171:818-822.
17. Haddad B, Deis S, Goffinet F, Paniel BJ, Cabrol D, Sibai BM. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks gestation. Am J Obstet Gynecol 2004;190:1590-1597.
18. Barrilleaux PS, Martin JN, Klauser CK, Bufkin L, May WL. Postpartum intravenous dexamethasone for severely preeclamptic patients without hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome: a randomized trial. Obstet Gynecol 2005;105:843-848.
19. Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau P-H, Papiernik E, Huon C, Lepercq J, Dehan M, Lacaze-Masmonteil T. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999;341:1190-1196.
20. Elimian A, Verma U, Canterino J, Shah J, Visintainer P, Tejani N. Effectiveness of antenatal steroids in obstetric subgroups. Obstet Gynecol 1999;93:174-179.
21. Spinillo A, Viazzo F, Colleoni R, Chiara A, Cerbo RM, Fazzi E. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol 2004;191:217-224.
22. Allen AC, Attenborough R, Dodds L, Luther ER, Pole J. Perinatal Care in Nova Scotia, 1988-1995. Report from the Nova Scotia Atlee Perinatal Database, Halifax (Canada): The Reproductive Care Program of Nova Scotia; 1996.
23. Statistics Canada, 2001 Census Nation Tables. http://www40.statcan.ca/ 101/cst01/demo.htm
24. Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol 1976;33:696-705.
25. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews 2006, Issue 3. Art No.: CD004454. DOI: 10.1002/14651858. CD004454.pub2.
26. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280:1690-1691.
27. Rose CH, Thigpen BD, Bofill JA, Cushman J, May WL, Martin JN. Obstetric implications of antepartum corticosteroid therapy for HELLP syndrome. Obstet Gynecol 2004;104:1011-1014.
28. Roelofsen AC, van Pampus MG, Aaroundse JG. The HELLP-syndrome: maternal-fetal outcome and followup of infants. J Perinat Med 2003;31:201-208.
29. Withagen MIJ, Visser W, Wallenburg HCS. Neonatal outcome of temporizing treatment in early onset pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2001;94:211-215.
30. Withagen MIJ, Wallenburg HCS, Steegers EAP, Hop WCJ, Visser W. Morbidity and development in childhood of infants born after temporizing treatment of early onset pre-eclampsia. BJOG 2005;112:1-5.
31. Fair M, Cyr M, Allen AC, Wen SW, Guyon G, MacDonald RC. An assessment of the validity of a computer system probabilistic record linkage of birth and infant death records in Canada. Chronic Dis Can 2000;21:8-13.
32. Fair M, Cyr M, Allen AC, Wen SW, Guyon G, MacDonald RC. Validation study for a record linkage of births and infant deaths in Canada. Catalogue No. 84F0013XIE. Ottawa: Statistics Canada; 1999.